Lisa A. Conte - Dec 27, 2022 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
CEO and President, Director
Signature
/s/ Lisa A. Conte
Stock symbol
JAGX
Transactions as of
Dec 27, 2022
Transactions value $
$0
Form type
4
Date filed
12/28/2022, 08:07 PM
Previous filing
Apr 6, 2022
Next filing
Apr 20, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Employee Stock Option (right to buy) Disposed to Issuer $0 -143K -100% $0.00* 0 Dec 27, 2022 Common Stock 143K $5.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was cancelled by mutual agreement of the reporting person and Jaguar Health, Inc. The reporting person received $300 as consideration for the cancellation.
F2 The option will vest ratably on a monthly basis over 36 months from the grant date, so long as the executive remains employed by the issuer.